Rafferty Asset Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-367,445
| Closed | -$783K | – | 1062 |
|
|
2024
Q4 | $783K | Buy |
367,445
+50,499
| +16% | +$108K | ﹤0.01% | 833 |
|
|
2024
Q3 | $887K | Sell |
316,946
-267,894
| -46% | -$750K | ﹤0.01% | 824 |
|
|
2024
Q2 | $1.36M | Sell |
584,840
-405,863
| -41% | -$946K | 0.01% | 743 |
|
|
2024
Q1 | $4.43M | Buy |
990,703
+761,695
| +333% | +$3.4M | 0.02% | 500 |
|
|
2023
Q4 | $735K | Sell |
229,008
-675,395
| -75% | -$2.17M | ﹤0.01% | 875 |
|
|
2023
Q3 | $2.87M | Buy |
904,403
+19,832
| +2% | +$62.9K | 0.02% | 513 |
|
|
2023
Q2 | $4.4M | Buy |
884,571
+207,534
| +31% | +$1.03M | 0.02% | 444 |
|
|
2023
Q1 | $3.34M | Sell |
677,037
-79,471
| -11% | -$393K | 0.02% | 483 |
|
|
2022
Q4 | $4.76M | Buy |
756,508
+296,677
| +65% | +$1.87M | 0.04% | 382 |
|
|
2022
Q3 | $4.97M | Buy |
459,831
+237,972
| +107% | +$2.57M | 0.05% | 339 |
|
|
2022
Q2 | $2.53M | Sell |
221,859
-346,059
| -61% | -$3.94M | 0.02% | 418 |
|
|
2022
Q1 | $5.17M | Buy |
567,918
+272,539
| +92% | +$2.48M | 0.03% | 386 |
|
|
2021
Q4 | $4.41M | Buy |
295,379
+164,098
| +125% | +$2.45M | 0.02% | 430 |
|
|
2021
Q3 | $3.37M | Buy |
131,281
+31,338
| +31% | +$805K | 0.02% | 416 |
|
|
2021
Q2 | $2.61M | Buy |
99,943
+13,360
| +15% | +$348K | 0.02% | 577 |
|
|
2021
Q1 | $3.06M | Buy |
86,583
+52,585
| +155% | +$1.86M | 0.02% | 483 |
|
|
2020
Q4 | $858K | Sell |
33,998
-27,279
| -45% | -$688K | 0.01% | 545 |
|
|
2020
Q3 | $2.31M | Buy |
61,277
+38,428
| +168% | +$1.45M | 0.03% | 373 |
|
|
2020
Q2 | $978K | Buy |
+22,849
| New | +$978K | 0.01% | 553 |
|
|
2020
Q1 | – | Sell |
-48,615
| Closed | -$1.26M | – | 605 |
|
|
2019
Q4 | $1.26M | Sell |
48,615
-10,811
| -18% | -$281K | 0.02% | 495 |
|
|
2019
Q3 | $1.62M | Sell |
59,426
-17,057
| -22% | -$465K | 0.03% | 437 |
|
|
2019
Q2 | $2.05M | Buy |
76,483
+21,650
| +39% | +$581K | 0.04% | 412 |
|
|
2019
Q1 | $1.59M | Buy |
+54,833
| New | +$1.59M | 0.03% | 458 |
|